Last reviewed · How we verify
Spinal analgesia — Competitive Intelligence Brief
marketed
Pain Management
Small molecule
Live · refreshed every 30 min
Target snapshot
Spinal analgesia (Spinal analgesia) — McGill University Health Centre/Research Institute of the McGill University Health Centre. Spinal analgesia delivers pain-relieving medications directly into the cerebrospinal fluid around the spinal cord to block pain signals at their source.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Spinal analgesia TARGET | Spinal analgesia | McGill University Health Centre/Research Institute of the McGill University Health Centre | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Spinal analgesia CI watch — RSS
- Spinal analgesia CI watch — Atom
- Spinal analgesia CI watch — JSON
- Spinal analgesia alone — RSS
Cite this brief
Drug Landscape (2026). Spinal analgesia — Competitive Intelligence Brief. https://druglandscape.com/ci/spinal-analgesia. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing